INTS · Intensity Therapeutics, Inc. · Suppliers & Customers
$2.80
-0.20 (-6.67%)
At close · Nov 9
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of September 30, 2026, our cash and cash equivalents were approximately $8.5 million. Based on our balances in cash and cash equivalents, our ability to continue our operations is dependent on obtaining additional capital, which is not within our control. As a result, we believe there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$9.90M
Shares
3.30M
Volume · Nov 9
15.84K
Avg daily vol (3M)
23.31K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones INTS names, and the companies that name INTS.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who INTS sells to, buys from and competes with
- 3 suppliers
- 0 customers
- 17 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.